HKSE - Delayed Quote HKD
ZYLOXTB-B (2190.HK)
At close: October 25 at 4:08 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
527,754.000
527,754.000
334,090.000
177,912.000
27,631.000
--
Cost of Revenue
142,766.000
142,766.000
81,421.000
46,031.000
11,344.000
--
Gross Profit
384,988.000
384,988.000
252,669.000
131,881.000
16,287.000
--
Operating Expense
529,422.000
529,422.000
474,855.000
350,215.000
114,070.000
--
Operating Income
-144,434.000
-144,434.000
-222,186.000
-218,334.000
-97,783.000
--
Net Non Operating Interest Income Expense
77,789.000
77,789.000
94,843.000
12,787.000
-306.000
--
Pretax Income
-78,734.000
-78,734.000
-113,555.000
-199,689.000
-100,468.000
--
Net Income Common Stockholders
-78,734.000
-78,734.000
-113,555.000
-199,689.000
-100,468.000
--
Diluted NI Available to Com Stockholders
-78,734.000
-78,734.000
-113,555.000
-199,689.000
-100,468.000
--
Basic EPS
-0.24
--
-0.34
-0.68
-0.31
-0.21
Diluted EPS
-0.24
--
-0.34
-0.68
-0.31
-0.21
Basic Average Shares
328,711.000
--
330,388.000
294,595.000
323,401.001
323,401.001
Diluted Average Shares
328,711.000
--
330,388.000
294,595.000
323,401.001
323,401.001
Total Operating Income as Reported
-156,523.000
-156,523.000
-208,398.000
-212,476.000
-100,162.000
--
Total Expenses
672,188.000
672,188.000
556,276.000
396,246.000
125,414.000
--
Net Income from Continuing & Discontinued Operation
-78,734.000
-78,734.000
-113,555.000
-199,689.000
-100,468.000
--
Normalized Income
-69,614.000
-69,614.000
-109,018.000
-213,634.000
-102,120.000
--
Interest Income
79,040.000
79,040.000
95,565.000
13,094.000
360.000
--
Interest Expense
1,251.000
1,251.000
722.000
307.000
666.000
--
Net Interest Income
77,789.000
77,789.000
94,843.000
12,787.000
-306.000
--
EBIT
-77,483.000
-77,483.000
-112,833.000
-199,382.000
-99,802.000
--
EBITDA
-41,603.000
-41,603.000
-86,565.000
-186,000.000
-90,164.000
--
Reconciled Cost of Revenue
142,766.000
142,766.000
81,421.000
46,031.000
11,344.000
--
Reconciled Depreciation
35,880.000
35,880.000
26,268.000
13,382.000
9,638.000
--
Net Income from Continuing Operation Net Minority Interest
-78,734.000
-78,734.000
-113,555.000
-199,689.000
-100,468.000
--
Total Unusual Items Excluding Goodwill
-9,120.000
-9,120.000
-4,537.000
13,945.000
1,652.000
--
Total Unusual Items
-9,120.000
-9,120.000
-4,537.000
13,945.000
1,652.000
--
Normalized EBITDA
-32,483.000
-32,483.000
-82,028.000
-199,945.000
-91,816.000
--
12/31/2019 - 7/5/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LFTSF LifeTech Scientific Corporation
0.2335
0.00%
4549.T Eiken Chemical Co., Ltd.
2,432.00
-1.54%
6849.T Nihon Kohden Corporation
2,204.00
+0.30%
7575.T Japan Lifeline Co., Ltd.
1,170.00
-0.85%
1789.HK AK MEDICAL
4.800
+4.58%
6609.HK HEARTCARE-B
19.980
-0.10%
2235.HK MICROTECH MED-B
4.410
0.00%
2291.HK SCIENTECH
17.280
-2.81%
2407.HK GAUSH MEDITECH
10.620
-6.18%
9996.HK PEIJIA-B
4.130
+0.24%